We are live on ! Find out more
RGC

Roberts, Glore & Co Portfolio holdings

AUM $364M
1-Year Est. Return 19.54%
This Fund
S&P 500
This Quarter Est. Return
+1.97%
1 Year Est. Return
+19.54%
3 Year Est. Return
+59.43%
5 Year Est. Return
+77.93%
10 Year Est. Return
+273.65%
AUM
$143M
AUM Growth
+$4.21M
Cap. Flow
+$2.41M
Cap. Flow %
1.68%
Top 10 Hldgs %
30.37%
Holding
149
New
10
Increased
30
Reduced
61
Closed
5

Sector Composition

Rank Sector Weight
1 Healthcare 23.2%
2 Financials 12.7%
3 Technology 11.44%
4 Industrials 10.68%
5 Consumer Staples 7.14%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
DGX icon
26
Quest Diagnostics
DGX
$25.8B
$1.67M 1.17%
18,188
-200
-1% -$17.2K
EXPD icon
27
Expeditors International
EXPD
$22B
$1.67M 1.16%
31,542
-1,100
-3% -$57.5K
WBA
28
DELISTED
Walgreens Boots Alliance
WBA
$1.52M 1.06%
18,337
-20
-0.1% -$1.65K
AGN
29
DELISTED
Allergan plc
AGN
$1.51M 1.06%
7,208
+830
+13% +$172K
STT icon
30
State Street
STT
$50.6B
$1.48M 1.03%
19,088
-301
-2% -$22.7K
ABT icon
31
Abbott
ABT
$181B
$1.47M 1.02%
38,156
+216
+0.6% +$8.56K
CHRW icon
32
C.H. Robinson
CHRW
$17.4B
$1.45M 1.01%
19,825
CEF icon
33
Sprott Physical Gold and Silver Trust
CEF
$7.37B
$1.36M 0.95%
120,225
+18,325
+18% +$229K
NSC icon
34
Norfolk Southern
NSC
$74.7B
$1.35M 0.94%
12,475
-50
-0.4% -$5.05K
KO icon
35
Coca-Cola
KO
$376B
$1.34M 0.94%
32,403
-450
-1% -$18.7K
RTX icon
36
RTX Corp
RTX
$286B
$1.27M 0.88%
18,401
+701
+4% +$46.5K
ESRX
37
DELISTED
Express Scripts Holding Company
ESRX
$1.24M 0.86%
18,030
+825
+5% +$59.1K
ETR icon
38
Entergy
ETR
$50.4B
$1.22M 0.85%
33,220
-200
-0.6% -$7.17K
BDX icon
39
Becton Dickinson
BDX
$45.1B
$1.11M 0.78%
6,905
-103
-1% -$17.1K
AMGN icon
40
Amgen
AMGN
$205B
$1.1M 0.77%
7,554
-25
-0.3% -$3.76K
USCI icon
41
US Commodity Index
USCI
$369M
$1.05M 0.73%
26,280
-400
-1% -$16.5K
VIG icon
42
Vanguard Dividend Appreciation ETF
VIG
$111B
$1M 0.7%
11,751
+185
+2% +$15.6K
VZ icon
43
Verizon
VZ
$193B
$997K 0.7%
18,674
-225
-1% -$11.2K
CME icon
44
CME Group
CME
$96.6B
$977K 0.68%
8,474
NVS icon
45
Novartis
NVS
$296B
$972K 0.68%
14,887
+390
+3% +$25.3K
FLO icon
46
Flowers Foods
FLO
$1.5B
$947K 0.66%
47,440
+5,410
+13% +$89K
TECH icon
47
Bio-Techne
TECH
$11.2B
$902K 0.63%
35,068
VWO icon
48
Vanguard FTSE Emerging Markets ETF
VWO
$120B
$901K 0.63%
25,185
-11,267
-31% -$413K
UNP icon
49
Union Pacific
UNP
$172B
$893K 0.62%
8,610
-10
-0.1% -$983
WMT icon
50
Walmart Inc
WMT
$886B
$883K 0.62%
38,304
-1,350
-3% -$31.5K

Similar funds

Roberts, Glore & Co's Q4 2016 Portfolio in Review

As of Q4 2016, Roberts, Glore & Co held 149 positions worth $143M, up 3% from $139M the previous quarter. Its ten largest holdings account for 30% of the portfolio.

Roberts, Glore & Co's Q4 2016 filing shows 10 new, 30 increased, 61 reduced and 5 closed positions. Its largest new stake was Vanguard Tax-Exempt Bond Index Fund: 14,300 shares worth $719K. The largest sale was Vanguard FTSE Emerging Markets ETF, an estimated $413K.

By sector, the portfolio is most concentrated in Healthcare at 23% of assets, down from 25% a quarter earlier, followed by Financials and Technology.

  • Roberts, Glore & Co's largest Q4 2016 buy was Vanguard Tax-Exempt Bond Index Fund: 14,300 shares worth $719K.
  • Roberts, Glore & Co added most to Invesco Taxable Municipal Bond ETF in Q4 2016, an estimated $559K increase.
  • Roberts, Glore & Co's biggest Q4 2016 reduction was Vanguard FTSE Emerging Markets ETF, cutting an estimated $413K.
  • Roberts, Glore & Co fully exited iShares MSCI EAFE ETF in Q4 2016, selling an estimated $295K.
  • Roberts, Glore & Co's ten largest holdings make up 30% of its $143M portfolio in Q4 2016.
  • Roberts, Glore & Co opened 10 new positions and closed 5 in Q4 2016.
  • Roberts, Glore & Co's portfolio value rose 3% quarter-over-quarter to $143M.

Based on Roberts, Glore & Co's 13F filing for Q4 2016, filed 9 Feb 2017.